Evidence map›Paper›PMID 41544105›Full record

ArticlePLoS computational biology2026

TCR2HLA: Calibrated inference of HLA genotypes from TCR repertoires enables identification of immunologically relevant metaclonotypes.

Koshlan Mayer-Blackwell, Anastasia Minervina, Mikhail Pogorelyy, Puneet Rawat, Melanie R Shapiro, Leeana D Peters, Emily S Ford, Amanda L Posgai, Kasi Vegesana, Samuel Minot and 6 more

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Koshlan Mayer-BlackwellVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0002-1652-4023
Anastasia MinervinaSt. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Mikhail PogorelyySt. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Puneet RawatDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID https://orcid.org/0000-0002-3822-8081
Melanie R ShapiroDepartment of Pathology, Immunology, and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.ORCID https://orcid.org/0000-0003-2090-0877
Leeana D PetersDepartment of Pathology, Immunology, and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Emily S FordVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Amanda L PosgaiDepartment of Pathology, Immunology, and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Kasi VegesanaSt. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.ORCID https://orcid.org/0000-0001-8847-3774
Samuel MinotVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
David M KoelleVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0003-1255-9023
Victor GreiffDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Philip BradleyPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Todd M BruskoDepartment of Pathology, Immunology, and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Paul G ThomasSt. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Andrew Fiore-GartlandVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0001-7627-2166

Funding

Household Respiratory Virus SARS-CoV-2 Transmission and Immunity Sub-Study (HRTS)U01AI144616 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GORDON, AUBREE L, THOMAS, PAUL G. · 2019 to 2025
$43.7M
Project 3P01AI042288 · NIAID · UNIVERSITY OF FLORIDA · PI Todd Michael Brusko · 1997 to 2026
$32.9M
PanCorVac (Center for Pan-Coronavirus Vaccine Development)P01AI165077 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KAWAOKA, YOSHIHIRO · 2021 to 2023
$11.6M
DECODING THE INTERACTIONS BETWEEN T CELL RECEPTORS AND PEPTIDE-MHCR01AI136514 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Paul G. Thomas · 2018 to 2026
$6.9M
Large Scale T Cell Epitope Discovery: Local and Systemic T cell Response to Herpes Simplex Virus75N93019C00063 · NIAID · UNIVERSITY OF WASHINGTON · PI MYER, TIM · 2019 to 2023
$5.5M
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases ResearchS10OD028685 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2020 to 2020
$2.0M
Fcγ Receptor-Mediated Pharmacogenomics of Antibody Therapies in Type 1 DiabetesK99DK140511 · NIDDK · UNIVERSITY OF FLORIDA · PI SHAPIRO, MELANIE R · 2024 to 2025
$265k
NIAID NIH HHS P01 AI042288NIAID NIH HHS P01 AI165077NIAID NIH HHS R01 AI136514NIAID NIH HHS U01 AI144616NIDDK NIH HHS K99 DK140511NIH HHS 75N93019C00063NIH HHS S10 OD028685
6 · The paper itself

Abstract

T cell receptors (TCRs) recognize peptides presented by polymorphic human leukocyte antigen (HLA) molecules, but HLA genotype data are often missing from TCR repertoire sequencing studies. To address this, we developed TCR2HLA, an open-source tool that infers HLA genotypes from TCRβ repertoires. Expanding on work linking public TRBV-CDR3 sequences to HLA genotypes, we incorporated "quasi-public" metaclonotypes - composed of rarer TCRβ sequences with shared amino acid features - enriched by HLA genotypes. Using four TCRβseq datasets from 3,150 individuals, we applied TRBV gene partitioning and locality-sensitive hashing to identify ~96,000 TCRβ features strongly associated with specific HLA alleles from 71M input TCRs. Binary HLA classifiers built with these features achieved high balanced accuracy (>0.9) across common HLA-A (9/12), B (9/12), C (6/13), DRB1 (11/11) alleles and prevalent DPA1/DPB1 (6/10), DQA1/DQB1 (8/17) heterodimers. We also introduced a high-sensitivity calibration to support predictions in samples with as few as 5,000 unique clonotypes. Calibrated predictions with confidence filtering improved reliability. Beyond genotype imputation, TCR2HLA enables the discovery of novel HLA- and exposure-associated TCRs, as shown by the identification of SARS-CoV-2 related TCRs in a large COVID-19 dataset lacking HLA data. TCR2HLA provides a scalable framework for bridging the gap between TCRseq data and HLA genotype for biomarker discovery.

Indexed as

HLA AntigensReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaSoftwareAllelesComputational BiologyCOVID-19GenotypeHumansHLA AntigensReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID41544105
PMCPMC12810895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.